scholarly journals A COMPREHENSIVE REVIEW OF MODE OF ACTION OF DRAKSHADI YOGA IN MANAGEMENT OF ASRIGDARA

2020 ◽  
Vol 8 (9) ◽  
pp. 4516-4519
Author(s):  
Meemansa 1 ◽  
Manish Kumar Saini
Keyword(s):  
Menstrual Cycle ◽  
Mode Of Action ◽  
Review Article ◽  
Uterine Bleeding ◽  
Dysfunctional Uterine Bleeding ◽  
Comprehensive Review ◽  
Menstrual Disorder ◽  
Basic Mode ◽  
Normal Menstrual Cycle ◽  
Main Motive

Asrigdara or dysfunctional uterine bleeding is a menstrual disorder causing the excessive or prolonged bleeding hence deteriorating the health of female. As per Ayurveda classics, according to its pathogenesis Pittashamaka, Vatanulomana, Rakta-Sthapaka, Rakta-Samgrahi, Agni-deepana and Garbhashaya-balya Chikitsa is beneficial in Asrigdara. Because the main motive in its management is to stop bleeding and achieve the normal menstrual cycle in terms of bleeding, duration and frequency, Acharaya Charaka also said its treatment to accomplish on the principles of management of Raktatisara, Raktapitta and Rakta ar-sha. Thus, Drakshadi yoga was taken in this review article from Sushruta Samhita Uttar Tantra 45/34 in reference to Raktapitta Chikitsa. Present study is concerning illumination on the basic mode of action of Drakshadi Yoga in treating the Asrigdara.

scholarly journals MENSTRUAL DISORDERS IN ADOLESCENTS

2004 ◽  
Vol 43 (153) ◽  
Author(s):  
Ganesh Dangal
Keyword(s):  
Menstrual Cycle ◽  
Premenstrual Syndrome ◽  
Uterine Bleeding ◽  
Diagnosis And Treatment ◽  
Treatment Modalities ◽  
Menstrual Disorders ◽  
Dysfunctional Uterine Bleeding ◽  
Menstrual Disorder ◽  
Menstrual Irregularities ◽  
Normal Menstrual Cycle

The health problems of adolescents are very special. Menstrual disorders such as amenorrhea, abnormal/excessive uterine bleeding, dysmenorrhea, and premenstrual syndrome are particularly common in adolescentgirls. Although menstrual irregularities may be normal during the early postmenarchal years, pathologicalconditions require proper and prompt management. This article reviews the topic: menstrual disorders anddiscusses their etiologies, diagnosis and treatment modalities. It also reviews the normal and abnormalmenstrual cycles. The knowledge of the normal menstrual cycle is very important in managing these disordersproperly.ABSTRACTDangal GKey Words: Adolescent, amenorrhea, dysfunctional uterine bleeding, dysmenorrhea,menstrual disorder, premenstrual syndrome.

Vaginal Bleeding

2020 ◽  
Keyword(s):  
Menstrual Cycle ◽  
Vaginal Bleeding ◽  
Abnormal Uterine Bleeding ◽  
Uterine Bleeding ◽  
Common Cause ◽  
Key Points ◽  
Normal Menstrual Cycle

Key Points Abnormal uterine bleeding refers to bleeding that is excessive or occurs outside normal cyclic menstruationAnovulatory uterine bleeding is the most common cause of abnormal uterine bleeding adolescents within 1–2 years of menarche.It is important to exclude pregnancy and infections prior to initiating treatment for anovulatory bleedingGoals of management for abnormal uterine bleeding include return to pattern of normal menstrual cycle and prevention of anemia.

scholarly journals EFFICACY OF ORMELOXIFENE IN MANAGEMENT OF DYSFUNCTIONAL UTERINE BLEEDING

2018 ◽  
Vol 11 (11) ◽  
pp. 195
Author(s):  
Umesh Sawarkar ◽  
Sarang Deshmukh ◽  
Ashwini Raut ◽  
Uma Bhosale ◽  
Ashok Shenoyk
Keyword(s):  
Menstrual Cycle ◽  
Therapeutic Response ◽  
Main Type ◽  
Uterine Bleeding ◽  
Voluntary Participation ◽  
Dysfunctional Uterine Bleeding ◽  
Bleeding Pattern ◽  
Hb Concentration ◽  
Study Participants ◽  
Pro Forma

Objective: The objective was to evaluate the efficacy of ormeloxifene in dysfunctional uterine bleeding (DUB) with respect to bleeding pattern and improvement in hemoglobin (Hb).Methods: This was an interventional study on 99 patients of DUB visiting the gynecology outpatient department over 1 year using semi-structured pro forma. After voluntary participation of patients, tablet ormeloxifene was given at the dose of 30 mg biweekly for 2 months. In case of a therapeutic response as informed by the patient, the dose was reduced to 30 mg weekly for a further period of 4 months. All patients were treated for 6 months. Type, amount, and duration of bleeding, frequency of menstrual cycle, passage of clots, and impact on Hb were assessed.Result and Observations: Menorrhagia was the main type of bleeding. 36–40 years of age group was the most common. After the intervention, 76.8% of women achieved a duration of bleeding of 4–5 days, and in 87% of women, menstrual cycle became regular. Passage of clots was reduced by 71.83%. Mean Hb concentration of study participants increased by 0.5 g/dl at the end of the study.Conclusion: Ormeloxifene is effective alternative and appears to be a promising option for the medical management of DUB.

scholarly journals Comparative Study of Desogestrel- Containing Oral Contraceptive and Levonorgestrel- Containing Oral Contraceptive in Dysfunctional Uterine Bleeding

2020 ◽  
Vol 11 (4) ◽  
pp. 5678-5684
Author(s):  
Swathi Suresh ◽  
Mariya Els Johny ◽  
Kiruba Shankari ◽  
Ahamed Irshath U ◽  
Yokesh M ◽  
...  
Keyword(s):  
Weight Gain ◽  
Oral Contraceptive ◽  
Side Effects ◽  
Menstrual Cycle ◽  
Blood Loss ◽  
Ethinyl Estradiol ◽  
Abnormal Uterine Bleeding ◽  
Uterine Bleeding ◽  
Dysfunctional Uterine Bleeding ◽  
Group D

Dysfunctional uterine bleeding is a type of abnormal uterine bleeding where vaginal bleeding occurs outside of the menstrual cycle in the absence of any known pelvic pathology. Dysfunctional uterine bleeding can be treated safely with hormone therapy. Combined oral contraceptives help in increased menstrual cycle regularity and decreased blood loss. In this study, a reliable drug for the dysfunctional uterine bleeding with maximum effectiveness and minimal side effects were assessed. This study was conducted on 120 cases of dysfunctional uterine bleeding. Patients who were diagnosed with dysfunctional uterine bleeding were randomly assigned into two groups. Group D and group L included patients who were given Ethinyl estradiol 0.02mg + desogestrel 0.15mg and Ethinyl estradiol 0.03mg + levonorgestrel 0.15mg respectively for the four consecutive 28- day cycles. Menstrual blood loss was assessed using the pictorial blood assessment chart (PBAC) score on 2nd and 4th months of recruitment. Side effects such as weight gain, acne and headache were assessed in both groups. This study shows 56.68% reduction in mean PBAC score in 2 months in desogestrel group whereas only 44.96% reduction in levonorgestrel group and 79.87% reduction in mean PBAC score in desogestrel group in 4 months whereas only 74.46% reduction in levonorgestrel group. Side effects like weight gain, acne and headache were more prominent in the levonorgestrel group than desogestrel group. Desogestrel containing combined oral contraceptive can be a useful and safe treatment for dysfunctional uterine bleeding.

scholarly journals A STUDY ON TEAR FILM PRODUCTION AND DRAINAGE IN WOMEN WITH DYSFUNCTIONAL UTERINE BLEEDING

2021 ◽  
pp. 1-2
Author(s):  
Aishwarya Thanasekaran ◽  
Thangerani Raajaseharan ◽  
S.R. Raajaseharan ◽  
Nihma Arif A M
Keyword(s):  
Menstrual Cycle ◽  
Tear Film ◽  
Meibomian Gland ◽  
Uterine Bleeding ◽  
Film Production ◽  
Dysfunctional Uterine Bleeding ◽  
Film Stability ◽  
Menstrual Cycles ◽  
Randomised Study ◽  
Tear Film Stability

AIM – To assess the tear film stability and the tear drainage in dysfunctional uterine bleeding women. MATERIALS AND METHODS : A randomised study of 50 women of fertile age and with irregular menstrual cycles for a period of 1 year were enrolled in this study. Tear production was evaluated with Schirmer I and II test, tear stability with tear breakup time, tear film meniscus, ocular surface stained with lissamine green and Meibomian gland count assessed. Tear drainage was assessed using Jones dye test. The data values of Schirmer's test 1 and 2 , TBUT and Jo RESULTS : nes dye test were found to be normal in all the patients. As the patients were tested randomly in different phases of their disrupted cycles, the differences in their tear film stability and production could not be commented. The fin CONCLUSION: dings of our study show that Meibomian glands exhibit a cyclic change in normal menstrual cycle whereas in irregular menstrual cycles, no changes were found in tear film production and drainage as women were in their different phases of irregular menstrual cycle

scholarly journals Thyroid Status in Patients with Dysfunctional Uterine Bleeding in a Tertiary Care Hospital of Assam

2016 ◽  
Vol 20 (1) ◽  
pp. 11-15
Author(s):  
Jadab K Phukan ◽  
Gautom K Saharia ◽  
Rohini Goswami
Keyword(s):  
Menstrual Cycle ◽  
Tertiary Care Hospital ◽  
Tertiary Care ◽  
Abnormal Uterine Bleeding ◽  
Clinical History ◽  
Thyroid Stimulating Hormone ◽  
Uterine Bleeding ◽  
Care Hospital ◽  
Thyroid Status ◽  
Dysfunctional Uterine Bleeding

ABSTRACT Background Dysfunctional uterine bleeding (DUB) is a major form of abnormal uterine bleeding, seen in at least 10% of all new outpatient department patients. The thyroid gland is known to play an important role in maintaining a healthy menstrual cycle. Aims To assess the thyroid hormone status in apparently euthyroid patients with DUB and to correlate it with incidence of DUB. Materials and methods Fifty DUB patients were selected on the basis of clinical history, examination, and relevant investigations. Equal numbers of age-matched women with normal menstrual cycle were taken as controls. Thyroid hormones, viz., thyroid-stimulating hormone, total triiodothyronine and tetraiodothyronine, were estimated by radioimmunoassay. Statistical analysis of the data was performed by using Microsoft Excel software. Results The most common menstrual abnormality was menorrhagia (48%) followed by metrorrhagia and polymenorrhea (14% each). Hypothyroidism was more prevalent among cases (85.7%) as compared with controls (14.3%). In patients with menorrhagia, 33.3% of patients had hypothyroidism. Conclusion Hypothyroidism occurs in DUB patients commonly. There is a need for mandatory thyroid screening in all patients with menstrual irregularities to help in early detection of the cause and treatment of DUB patients to avoid surgery. How to cite this article Phukan JK, Saharia GK, Goswami R. Thyroid Status in Patients with Dysfunctional Uterine Bleeding in a Tertiary Care Hospital of Assam. Indian J Med Biochem 2016;20(1):11-15.

scholarly journals A study of thyroid dysfunction in dysfunctional uterine bleeding

2018 ◽  
Vol 7 (3) ◽  
pp. 1002 ◽  
Author(s):  
Sujata Singh ◽  
Shradhanjali Sahoo ◽  
Pravat Chandra Das
Keyword(s):  
Thyroid Dysfunction ◽  
Uterine Bleeding ◽  
Aetiological Factor ◽  
Obstetrics And Gynecology ◽  
Thyroid Disorder ◽  
Age Group ◽  
Dysfunctional Uterine Bleeding ◽  
Menstrual Disorder ◽  
Menstrual Irregularities ◽  
Menstrual Pattern

Background: The objective of the study was to evaluate the prevalence of thyroid disorder in dysfunctional uterine bleeding and to assess the menstrual pattern in women with thyroid disorders.Methods: The present study was conducted on 104 patients who presented with dysfunctional uterine bleeding in gynecology OPD/IPD Department of Obstetrics and Gynecology, SCBMCH, Cuttack, India.Results: Among the 104 women 16 (15.3%) had hypothyroidism, 3 (2.8%) had hyperthyroidism and 75 (72.1%) were euthyroid and 10(9.6%) subclinical hypothyroidisim. Menorrhagia was the most common menstrual disorder in hypothyroidism and oligomenorrhoea in hyperthyroidism. In the present study the age group of 41-50 year and multyparity (para-2) and commonest are menorrhagic 42 (40.38%). Menorrhagia in hypothyroidisim 15 (72.4%) cases and oligomenorrhoea in hyperthyroidisim 3 (10.3%).Conclusions: Thyroid dysfunction should be considered as an important aetiological factor in menstrual disturbances and thyroid assessment should be done in all patients with menstrual irregularities. Therefore, to conclude any type of menstrual abnormality should be considered as a possible presenting symptom of thyroid dysfunction and it may even indicate subclinical abnormality, evaluation of thyroid would avoid unnecessary surgeries and exposure to hormones.

Sign in / Sign up

Export Citation Format

Share Document